TRIB2 and ovarian carcinoma: As summarized in Table 2, a multifunctional role of TRIB2 as an oncogenic protein has been described in numerous cancers where it is overexpressed, including melanoma [62], leukemias [63,64], pancreatic cancer [42], liver cancer [10], epithelial ovarian cancer [65] and lung cancer [47,66].